Senzime AB (publ)
Senzime AB (publ), a medical device company, develops, manufactures, and markets algorithm-powered patient monitoring systems to increase patient safety during and after surgery in Europe and the United States. The company offers TetraGraph, a quantitative neuromuscular transmission monitor, which supports neuromuscular blockade management from induction to recovery; and ExSpiron, a non-invasive … Read more
Senzime AB (publ) (SNZZF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: -0.068x
Based on the latest financial reports, Senzime AB (publ) (SNZZF) has a cash flow conversion efficiency ratio of -0.068x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-25.35 Million) by net assets ($371.40 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Senzime AB (publ) - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how Senzime AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Senzime AB (publ) Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Senzime AB (publ) ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
0RD9
LSE:0RD9
|
N/A |
|
STPCF
OTCGREY:STPCF
|
N/A |
|
Regis Corporation Common Stock
NYSE:RGS
|
0.009x |
|
West Wits Mining Limited
PINK:WMWWF
|
0.000x |
|
Aft Pharmaceuticals Ltd
AU:AFP
|
-0.006x |
|
Freightos Limited Ordinary shares
NASDAQ:CRGO
|
-0.088x |
|
Verde Resources Inc
OTCQB:VRDR
|
-0.021x |
|
Muhibbah Engineering M Bhd
KLSE:5703
|
-0.007x |
Annual Cash Flow Conversion Efficiency for Senzime AB (publ) (2013–2024)
The table below shows the annual cash flow conversion efficiency of Senzime AB (publ) from 2013 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $345.86 Million | $-105.94 Million | -0.306x | -0.72% |
| 2023-12-31 | $375.48 Million | $-114.19 Million | -0.304x | +41.77% |
| 2022-12-31 | $261.90 Million | $-136.78 Million | -0.522x | +3.31% |
| 2021-12-31 | $150.58 Million | $-81.33 Million | -0.540x | -225.94% |
| 2020-12-31 | $231.35 Million | $-38.34 Million | -0.166x | -2.09% |
| 2019-12-31 | $163.69 Million | $-26.57 Million | -0.162x | -55.95% |
| 2018-12-31 | $167.41 Million | $-17.42 Million | -0.104x | -18.93% |
| 2017-12-31 | $140.46 Million | $-12.29 Million | -0.088x | -15.36% |
| 2016-12-31 | $131.87 Million | $-10.00 Million | -0.076x | +45.82% |
| 2015-12-31 | $45.81 Million | $-6.41 Million | -0.140x | -60.41% |
| 2014-12-31 | $53.33 Million | $-4.65 Million | -0.087x | +39.87% |
| 2013-12-31 | $37.41 Million | $-5.43 Million | -0.145x | -- |